-Dow Jones
Morgan Stanley Maintains Overweight on Facebook, Raises Price Target to $400
Morgan Stanley analyst Brian Nowak maintains Facebook (NASDAQ:FB) with a Overweight and raises the price target from $375 to $400.
Related Posts
Mid-Day Market Update: Nasdaq Rises 1%; BridgeBio Pharma Shares Plunge
Midway through trading Monday, the Dow traded up 0.54% to 36,146.21 while the NASDAQ rose 1.04% to 15,815.70. The S&P also rose, gaining 0.87% to 4,766.92.
Truist Securities Downgrades MEI Pharma to Hold
Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.
Colliers Securities Initiates Coverage On Decarbonization Plus with Buy Rating, Announces Price Target of $15
Colliers Securities analyst Michael Shlisky initiates coverage on Decarbonization Plus (NASDAQ:DCRB) with a Buy rating and announces Price Target of $15.